299 related articles for article (PubMed ID: 23730942)
1. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities.
Coffin PO; Sullivan SD
J Med Econ; 2013 Aug; 16(8):1051-60. PubMed ID: 23730942
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal.
Coffin PO; Sullivan SD
Ann Intern Med; 2013 Jan; 158(1):1-9. PubMed ID: 23277895
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom.
Langham S; Wright A; Kenworthy J; Grieve R; Dunlop WCN
Value Health; 2018 Apr; 21(4):407-415. PubMed ID: 29680097
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users.
Acharya M; Chopra D; Hayes CJ; Teeter B; Martin BC
Value Health; 2020 Apr; 23(4):451-460. PubMed ID: 32327162
[TBL] [Abstract][Full Text] [Related]
5. The distribution of naloxone to heroin users.
Darke S; Hall W
Addiction; 1997 Sep; 92(9):1195-9. PubMed ID: 9374020
[TBL] [Abstract][Full Text] [Related]
6. Summaries for patients: naloxone for heroin overdose reversal.
Ann Intern Med; 2013 Jan; 158(1):I-30. PubMed ID: 23277911
[No Abstract] [Full Text] [Related]
7. Cost-effectiveness of naloxone kits in secondary schools.
Cipriano LE; Zaric GS
Drug Alcohol Depend; 2018 Nov; 192():352-361. PubMed ID: 30321745
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of alternative naloxone distribution strategies: First responder and lay distribution in the United States.
Townsend T; Blostein F; Doan T; Madson-Olson S; Galecki P; Hutton DW
Int J Drug Policy; 2020 Jan; 75():102536. PubMed ID: 31439388
[TBL] [Abstract][Full Text] [Related]
9. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study.
Seal KH; Thawley R; Gee L; Bamberger J; Kral AH; Ciccarone D; Downing M; Edlin BR
J Urban Health; 2005 Jun; 82(2):303-11. PubMed ID: 15872192
[TBL] [Abstract][Full Text] [Related]
10. Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people who inject drugs: a cost-effectiveness modelling study.
Uyei J; Fiellin DA; Buchelli M; Rodriguez-Santana R; Braithwaite RS
Lancet Public Health; 2017 Mar; 2(3):e133-e140. PubMed ID: 29253386
[TBL] [Abstract][Full Text] [Related]
11. The Rising Price of Naloxone - Risks to Efforts to Stem Overdose Deaths.
Gupta R; Shah ND; Ross JS
N Engl J Med; 2016 Dec; 375(23):2213-2215. PubMed ID: 27959694
[No Abstract] [Full Text] [Related]
12. Impact of a community-based naloxone distribution program on opioid overdose death rates.
Naumann RB; Durrance CP; Ranapurwala SI; Austin AE; Proescholdbell S; Childs R; Marshall SW; Kansagra S; Shanahan ME
Drug Alcohol Depend; 2019 Nov; 204():107536. PubMed ID: 31494440
[TBL] [Abstract][Full Text] [Related]
13. Challenges with take-home naloxone in reducing heroin mortality: a review of fatal heroin overdose cases in Victoria, Australia.
Stam NC; Gerostamoulos D; Smith K; Pilgrim JL; Drummer OH
Clin Toxicol (Phila); 2019 May; 57(5):325-330. PubMed ID: 30451007
[TBL] [Abstract][Full Text] [Related]
14. [Distribution of naloxone to prevent death from heroin overdose. Study of opioid dependent patients' attitudes to be part of the antidote program].
Håkansson A; Vedin A; Wallin C; Kral AH
Lakartidningen; 2013 Jul 17-Aug 6; 110(29-31):1340-2. PubMed ID: 23980443
[No Abstract] [Full Text] [Related]
15. Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond.
Lenton S; Dietze P; Olsen A; Wiggins N; McDonald D; Fowlie C
Drug Alcohol Rev; 2015 Jul; 34(4):404-11. PubMed ID: 25272281
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care.
Schackman BR; Leff JA; Polsky D; Moore BA; Fiellin DA
J Gen Intern Med; 2012 Jun; 27(6):669-76. PubMed ID: 22215271
[TBL] [Abstract][Full Text] [Related]
17. Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities.
Beletsky L; Ruthazer R; Macalino GE; Rich JD; Tan L; Burris S
J Urban Health; 2007 Jan; 84(1):126-36. PubMed ID: 17146712
[TBL] [Abstract][Full Text] [Related]
18. Do heroin overdose patients require observation after receiving naloxone?
Willman MW; Liss DB; Schwarz ES; Mullins ME
Clin Toxicol (Phila); 2017 Feb; 55(2):81-87. PubMed ID: 27849133
[TBL] [Abstract][Full Text] [Related]
19. What heroin users tell us about overdose.
Baca CT; Grant KJ
J Addict Dis; 2007; 26(4):63-8. PubMed ID: 18032233
[TBL] [Abstract][Full Text] [Related]
20. Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial.
Strang J; Bird SM; Parmar MK
J Urban Health; 2013 Oct; 90(5):983-96. PubMed ID: 23633090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
